The Latest Breaking News from HRSA

A federal appeals court has revived a proposed class action accusing four major drugmakers of conspiring to restrict a government-mandated drug discount program, allegedly driving up costs for safety-net hospitals and clinics serving low-income patients.

Three major pharmaceutical companies — Amgen Inc. (NASDAQ:AMGN), Eli Lilly and Co (NYSE:LLY), and UCB SA (OTC:UCBJY) (OTC:UCBJF) — are suing U.S. Secretary of Health and Human Services (HHS) Robert F. Kennedy Jr. over the way his department is handling a drug discount program.

Eli Lilly is taking the HRSA to court for allegedly blocking the pharma's discount plan.

The patient allegedly mouthed the words ‘help me’ ahead of the organ retrieval procedure

Department of Health and Human Services is investing $100 million in nursing workforce.

A federal program in remote New Mexico has helped hundreds of pregnant mothers stay healthy, but it's running out of time and money despite a growing national maternity care crisis.

The ruling is based on separation of powers and Religious Freedom Restoration Act grounds.

WASHINGTON — The Health Resources and Services Administration on Wednesday unveiled plans to break up the private nonprofit overseeing the nation’s organ transplantation system, and called on Congress to help.

More than 100,000 Americans are currently waiting for an organ and an estimated 17 people die each day on the waiting list.